MedTech Resources

Device type · MBX

Stimulator, Thalamic, Epilepsy, Implanted

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about MBX: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

MBX

Neurology

Device class

Class III

FDA decisions since 2015

1

510(k), De Novo and PMA

Adverse event reports

98

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Stimulator, Thalamic, Epilepsy, Implanted
Product code
MBX
Device class
Class III
Review panel
Neurology

Latest FDA decisions

All decisions for MBX

Reports received

98

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

56

57% of reports

Injury reports

42

43% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 232000
Jan 243100
Feb 249200
Mar 242100
Apr 241100
May 247300
Jun 240100
Jul 242600
Aug 247300
Sep 243100
Oct 241410
Nov 240400
Dec 247200
Jan 258200
Feb 253300
Mar 257400
Apr 255100
May 256100
Jun 251200
Jul 255500
Aug 252100
Sep 253100
Oct 259000
Nov 254300
Dec 255200
Jan 263400
Feb 264000
Mar 263400
Apr 2610100
May 262300
Jun 263300
Jul 264300
Aug 266700
Sep 265800
Oct 267400
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Adverse Event Without Identified Device or Use Problem17
  • High impedance16
  • Failure to Deliver Energy14
  • Insufficient Device Problem Information13
  • Battery Problem8
  • Patient Device Interaction Problem8
  • Therapeutic or Diagnostic Output Failure7
  • Break6
  • Charging Problem6
  • Communication or Transmission Problem6

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions48
  • Convulsion/Seizure22
  • Insufficient Information13
  • Unspecified Infection7
  • Cognitive Changes6
  • Electric Shock6
  • Discomfort4
  • Intracranial Hemorrhage4
  • Burning Sensation3
  • Pain3

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recalls for this product code in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.